Logo
A

ACU-Serve

152 employees

At ACU-Serve, we go beyond traditional revenue cycle management to help healthcare providers optimize operations, improve cash flow, and enhance patient care. Our expertise spans HME, Specialty Pharmacy, Home Infusion, and Resupply, delivering tailored solutions that drive efficiency and financial performance. Rather than simply adding more resources to address operational challenges, we take a strategic approach—optimizing your existing systems, streamlining workflows, and leveraging advanced technology to fill gaps and improve results. Our highly trained, U.S.-based management team provides hands-on support, ensuring seamless integration with your organization and fostering long-term success. Why ACU-Serve? End-to-End Revenue Cycle Management – From intake to cash postings, we provide a comprehensive solution designed to maximize reimbursements and minimize denials. Resupply Expertise – Our patient-first, technology-enabled resupply program reduces attrition and improves compliance, helping you recover lost revenue and drive growth. Infusion & Specialty Pharmacy Solutions – We provide specialized revenue cycle services to support the unique needs of Home Infusion, AICs, and Specialty Pharmacy, ensuring streamlined billing and faster payments. Compliance & Quality at Our Core – Our unwavering commitment to regulatory excellence gives our clients confidence in their revenue cycle processes. Technology-Driven Efficiency – We integrate with your existing software, optimizing performance without requiring costly system overhauls. ACU-Serve isn't just a billing service—we're an extension of your business, bringing the expertise, insight, and innovation needed to collect more, faster, while allowing you to focus on what matters most: patient care. ACU-Serve can help you scale your business with Results That Matter.

Basic info

Industry

Hospitals and Health Care

Sectors

Hospitals and Health Care

Funding rounds raised

A

ACU-Serve raised undisclosed on November 19, 2023

Investors: Lovell Minnick Partners

FAQ